🇺🇸 FDA
Patent

US 6787145

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

expired A61KA61K38/00A61K39/00

Quick answer

US patent 6787145 (Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K39/00